Macimorelin (Macrilen)
Overview
An orally bioavailable growth hormone secretagogue approved as a diagnostic agent for adult growth hormone deficiency (AGHD). Macimorelin stimulates GH release via GHS-R1a agonism, and the GH response to a standardized oral dose is used to confirm or exclude AGHD.
Mechanism of Action
It offers a simpler, better-tolerated alternative to the insulin tolerance test and GHRH-arginine test for GH deficiency diagnosis..
Research Summary & Key Findings
FDA-approved in 2017 as a diagnostic test for AGHD. Demonstrated 87% sensitivity and 96% specificity in clinical validation studies compared to the insulin tolerance test. Single oral dose produces measurable GH peak within 30-90 minutes. Well-tolerated with dysgeusia being the most common side effect (Garcia et al., J Clin Endocrinol Metab, 2018).
Clinical Status
Macimorelin (Macrilen) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.
Administration Routes
Related Peptides in Hormone
CJC-1295
In Clinical TrialsA synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that binds to albumin, ...
View detailsIpamorelin
In Clinical TrialsA highly selective growth hormone secretagogue that acts on ghrelin/GHS receptors in the pituitary gland to stimulate GH...
View detailsSermorelin
FDA ApprovedA synthetic 29-amino acid analog of GHRH representing the shortest fully functional fragment of the native 44-amino acid...
View detailsTesamorelin (Egrifta)
FDA ApprovedA synthetic GHRH analog consisting of the 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid modification...
View detailsFind a Provider
Find a verified provider who offers Macimorelin (Macrilen) therapy in your area.
Browse Provider MapFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Macimorelin (Macrilen).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.